超声引导下微波消融联合超声造影与传统术式治疗甲状腺微小乳头状癌的疗效评估
Evaluation of the Efficacy of Ultrasound-Guided Microwave Ablation Combined with Contrast-Enhanced Ultrasound versus Traditional Surgical Procedures for the Treatment of Papillary Thyroid Microcarcinoma
DOI: 10.12677/acm.2026.1641291, PDF,   
作者: 戴晓彬*:青岛大学青岛医学院,山东 青岛;郑 芳#:青岛市市立医院东院普通超声科,山东 青岛
关键词: 甲状腺微小乳头状癌微波消融生活质量Papillary Thyroid Microcarcinoma Microwave Ablation Quality of Life
摘要: 本研究回顾性分析了115例甲状腺微小乳头状癌(PTMC)患者,比较超声引导下微波消融联合超声造影(消融组,52例)与传统手术(手术组,63例)的疗效。结果显示,消融组所有病灶均一次性完全消融,并在随访18个月内完全吸收,消融组与手术组在淋巴结转移和复发率方面无显著差异。然而,消融组在安全性及术后生活质量方面优势明显:并发症发生率显著更低,手术时间、住院时间更短,术后疼痛更轻,且无颈部瘢痕,无需引流。生活质量评估显示,消融组在声音、心理、疤痕等方面问题更少,术后甲状腺功能(TSH、FT3、FT4)也优于手术组。研究表明,微波消融治疗PTMC安全有效,兼具微创、恢复快、并发症少等优点,能更好保护甲状腺功能并提升患者生活质量,有望成为介于主动监测与手术切除之间的理想治疗选择。
Abstract: This study retrospectively analyzed 115 patients with papillary thyroid microcarcinoma (PTMC) and compared the efficacy of ultrasound-guided microwave ablation combined with contrast-enhanced ultrasound (ablation group, 52 cases) with that of traditional surgery (surgery group, 63 cases). The results showed that all lesions in the ablation group were completely ablated in a single session and fully absorbed within an 18-month follow-up period, with no significant differences in lymph node metastasis or recurrence rates between the ablation and surgery groups. However, the ablation group demonstrated significant advantages in safety and postoperative quality of life: the incidence of complications was significantly lower, the procedure time and hospital stay were shorter, postoperative pain was milder, and there were no neck scars or need for drainage. Quality of life assessments indicated that the ablation group had fewer issues related to voice, psychological well-being, and scarring, and postoperative thyroid function (TSH, FT3, FT4) was better than that of the surgery group. The study suggests that microwave ablation is a safe and effective treatment for PTMC, offering the advantages of being minimally invasive, having a faster recovery, and having fewer complications. It also better preserves thyroid function and improves patients’ quality of life, making it a promising treatment option between active surveillance and surgical resection.
文章引用:戴晓彬, 郑芳. 超声引导下微波消融联合超声造影与传统术式治疗甲状腺微小乳头状癌的疗效评估[J]. 临床医学进展, 2026, 16(4): 650-660. https://doi.org/10.12677/acm.2026.1641291

参考文献

[1] Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D.M., Piñeros, M., Znaor, A., et al. (2021) Cancer Statistics for the Year 2020: An Overview. International Journal of Cancer, 149, 778-789. [Google Scholar] [CrossRef] [PubMed]
[2] Miranda-Filho, A., Lortet-Tieulent, J., Bray, F., Cao, B., Franceschi, S., Vaccarella, S., et al. (2021) Thyroid Cancer Incidence Trends by Histology in 25 Countries: A Population-Based Study. The Lancet Diabetes & Endocrinology, 9, 225-234. [Google Scholar] [CrossRef] [PubMed]
[3] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[4] 肖婧, 杨昱. 甲状腺乳头状癌患者的预后及相关因素分析[J]. 中国卫生统计, 2019, 36(5): 740-742.
[5] Zhang, J. and Xu, S. (2024) High Aggressiveness of Papillary Thyroid Cancer: From Clinical Evidence to Regulatory Cellular Networks. Cell Death Discovery, 10, Article No. 378. [Google Scholar] [CrossRef] [PubMed]
[6] Jeon, M.J., Kim, W.G., Kwon, H., Kim, M., Park, S., Oh, H., et al. (2017) Clinical Outcomes after Delayed Thyroid Surgery in Patients with Papillary Thyroid Microcarcinoma. European Journal of Endocrinology, 177, 25-31. [Google Scholar] [CrossRef] [PubMed]
[7] Gartland, R.M. and Lubitz, C.C. (2018) Impact of Extent of Surgery on Tumor Recurrence and Survival for Papillary Thyroid Cancer Patients. Annals of Surgical Oncology, 25, 2520-2525. [Google Scholar] [CrossRef] [PubMed]
[8] Pazaitou-Panayiotou, K., Capezzone, M. and Pacini, F. (2007) Clinical Features and Therapeutic Implication of Papillary Thyroid Microcarcinoma. Thyroid, 17, 1085-1092. [Google Scholar] [CrossRef] [PubMed]
[9] Hay, I.D. (2007) Management of Patients with Low-Risk Papillary Thyroid Carcinoma. Endocrine Practice, 13, 521-533. [Google Scholar] [CrossRef] [PubMed]
[10] 国家卫生健康委能力建设和继续教育中心甲状腺微创介入学组, 中国研究型医院学会超声医学专业委员会, 中国医学影像技术研究会, 等. 甲状腺低危微小乳头状癌超声引导热消融治疗专家共识[J]. 中国医学影像学杂志, 2026, 34(1): 3-12.
[11] Hegedüs, L. (2004) The Thyroid Nodule. New England Journal of Medicine, 351, 1764-1771. [Google Scholar] [CrossRef] [PubMed]
[12] Lim, H., Devesa, S.S., Sosa, J.A., Check, D. and Kitahara, C.M. (2017) Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA, 317, 1338-1348. [Google Scholar] [CrossRef] [PubMed]
[13] Ito, Y., Miyauchi, A., Kihara, M., Higashiyama, T., Kobayashi, K. and Miya, A. (2014) Patient Age Is Significantly Related to the Progression of Papillary Microcarcinoma of the Thyroid under Observation. Thyroid, 24, 27-34. [Google Scholar] [CrossRef] [PubMed]
[14] Zhang, M., Tufano, R.P., Russell, J.O., Zhang, Y., Zhang, Y., Qiao, Z., et al. (2020) Ultrasound-Guided Radiofrequency Ablation versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of over 5 Years’ Follow-Up. Thyroid, 30, 408-417. [Google Scholar] [CrossRef] [PubMed]
[15] Mauri, G., Hegedüs, L., Bandula, S., Cazzato, R.L., Czarniecka, A., Dudeck, O., et al. (2021) European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions. European Thyroid Journal, 10, 185-197. [Google Scholar] [CrossRef] [PubMed]
[16] Haugen, B.R., Alexander, E.K., Bible, K.C., Doherty, G.M., Mandel, S.J., Nikiforov, Y.E., et al. (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26, 1-133. [Google Scholar] [CrossRef] [PubMed]
[17] Husson, O., Mols, F. and van de Poll-Franse, L.V. (2011) The Relation between Information Provision and Health-Related Quality of Life, Anxiety and Depression among Cancer Survivors: A Systematic Review. Annals of Oncology, 22, 761-772. [Google Scholar] [CrossRef] [PubMed]